Work

Breast Cancer Patients with Very High Tumor HER2 Expression Levels Might Not Benefit from Treatment with Trastzumab Plus Chemotherapy: A Retrospective Exploratory Analysis of the FinHer Trial.

Year: 2009

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/0008-5472.sabcs-09-5083

Authors: H. Joensuu, J. Sperinde, M. Leinonen, W. Huang, J. Weidler, P. Bono, J. Isola, P. Kellokumpu-Lehtinen, M. Bates

Institutions: Helsinki University Hospital, Tampere University Hospital

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2003158932

Cites:

Cited by:

Related to: 10